Lipid Decision Tool

Risk calculator

Patient details
Sex
years
mmol/L
mmol/L
mmHg
µmol/L
mL/min
Diabetes
Current smokerany cigarette in past 30 days
On BP medication
On a statinPREVENT only
Family history of premature CVD1st-degree relative: male <55, female <65 · doubles Framingham risk (age 30–59, no diabetes)
Optional — refines PREVENT
%
mg/mmol
Not in risk scores — used by the algorithms
mmol/L
g/L
HIV on stable ARTACC/AHA only

PREVENT reports ASCVD risk (not total CVD); postal-code social deprivation is not used, and when both HbA1c and UACR are entered the full model treats it as missing, as the AHA calculator does without a ZIP code. Framingham reports 10-year total CVD risk using the CCS points method, doubled for family history as in the CCS modified FRS.

Adults 30–79 · no clinical ASCVD

PREVENT + risk enhancers

PREVENT 10-yr ASCVD
—
PREVENT 30-yr ASCVD (ages 30–59)
—
Enter the patient’s details on the left.
Framingham 10-yr CVD (CCS modified)—

Lipid treatment algorithm

Suggested action — ACC/AHA

Enter the patient’s details and press Calculate. The matching boxes below will be highlighted.
0Skip the calculator — treat directlyClinical ASCVD → secondary prevention (not covered here)
APPLIESLDL-C ≥4.9 mmol/LMax-tolerated statin; assess for FH. Don’t use risk calculators. Goal LDL-C <2.6 (<1.8 if HeFH).
APPLIESDiabetes, age 40–75Moderate statin 1. Consider high-intensity if multiple risk factors 2a.
APPLIESCKD stage 3–4, age 40–75eGFR 15–59: LDL-lowering therapy regardless of LDL-C.
APPLIESHIV on stable ART, 40–75Statin recommended 1 to prevent a first ASCVD event.
1Calculate — PREVENT 10-yr ASCVD riskFor LDL-C 1.8–4.8 mmol/L
LOW<3%
Lifestyle counseling 1 Age 30–59: check 30-yr risk. Consider moderate statin 2a if:
• LDL-C 4.1–4.8, or
• 30-yr ASCVD risk ≥10%
BORDERLINE3–<5%
Discuss; check risk enhancers ↓ 2a Enhancers present → consider moderate statin 2a, 30–49% LDL-C ↓ hsCRP ≥2 mg/L ×2 → consider high-intensity 2a Goal LDL-C <2.6 · non-HDL <3.4
INTERMEDIATE5–<10%
After discussion: at least moderate statin 1, 30–49% ↓ Upper end of range → high-intensity 1, ≥50% ↓ Risk enhancers ↓ favor starting and higher intensity Goal LDL-C <2.6 · non-HDL <3.4
HIGH≥10%
High-intensity statin 1, ≥50% LDL-C ↓ Not at goal on max statin → consider ezetimibe 2a Goal LDL-C <1.8 · non-HDL <2.6
2Personalize — risk enhancersTick what applies · mainly for borderline & intermediate · 0 selected